DTIC Public Document 38234b816d8b50692ae3b833d02bdc2b
Document Details
- Document Type
- Cost Item
- Publication Date
- Oct 01, 2017
- Source ID
- 38234b816d8b50692ae3b833d02bdc2b
- Current Year Amount Norm
- 0
- Group Name
- Product Development
- Name
- HFV - HW S - Ebola Response Phase 2 clinical trials for TKM-Ebola targeting Guinea Variant
- Performing Activity
- Tekmira Pharmaceuticals Corp.
- Prior Year Amount Norm
- 9834000